Sensei Biotherapeutics Faces Delisting Concerns
Ticker: SNSE · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Sensei Biotherapeutics might get delisted, stock could tank.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on July 9, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The earliest event reported was on July 2, 2025. The company is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This filing indicates potential issues with Sensei Biotherapeutics' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- July 2, 2025 (date) — Earliest event reported
- July 9, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Rockville, MD (location) — Principal executive offices
FAQ
What specific listing rule or standard has Sensei Biotherapeutics failed to satisfy?
The filing does not specify the exact rule or standard that Sensei Biotherapeutics has failed to satisfy, only that a notice of delisting or failure to satisfy such a rule has been issued.
What is the earliest date of the event reported in this 8-K?
The earliest event reported in this 8-K was on July 2, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on July 9, 2025.
Where are Sensei Biotherapeutics' principal executive offices located?
Sensei Biotherapeutics, Inc.'s principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the company's Standard Industrial Classification (SIC) code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).